ReviewBioengineering & translational medicine2017

Specific targeting of the deubiquitinase and E3 ligase families with engineered ubiquitin variants.

Maryna Gorelik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.